BD to Present at Wells Fargo 2025 Healthcare Conference
BD (NYSE:BDX), a leading global medical technology company, has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference. The company's presentation is scheduled for Wednesday, September 3, 2025, at 8:00 a.m. Eastern Time.
Investors and interested parties can access the live webcast of the presentation through BD's investor relations website at investors.bd.com. A replay will be made available on the same platform after the event concludes.
BD (NYSE:BDX), azienda leader globale nel settore della tecnologia medica, ha annunciato la propria partecipazione alla Wells Fargo 2025 Healthcare Conference. La presentazione è programmata per mercoledì 3 settembre 2025 alle 8:00 ora orientale.
Investitori e interessati potranno seguire la diretta in webcast tramite il sito investor relations di BD all'indirizzo investors.bd.com. Una registrazione sarà disponibile sullo stesso sito dopo la conclusione dell'evento.
BD (NYSE:BDX), una empresa líder mundial en tecnología médica, ha anunciado su participación en la Wells Fargo 2025 Healthcare Conference. La presentación está programada para miércoles 3 de septiembre de 2025 a las 8:00 a.m. hora del Este.
Los inversores y otras personas interesadas podrán acceder a la retransmisión en directo a través del sitio de relaciones con inversores de BD en investors.bd.com. Tras el evento se publicará una grabación en la misma plataforma.
BD (NYSE:BDX), 글로벌 의료기술 선도 기업이 Wells Fargo 2025 Healthcare Conference에 참여한다고 발표했습니다. 회사 발표는 2025년 9월 3일 수요일 동부 표준시 기준 오전 8:00에 예정되어 있습니다.
투자자 및 관심 있는 분들은 BD 투자자 관계 웹사이트 investors.bd.com을 통해 프레젠테이션 실시간 웹캐스트에 접속할 수 있습니다. 행사 종료 후 동일한 플랫폼에 다시보기 영상이 게시될 예정입니다.
BD (NYSE:BDX), société mondiale de premier plan dans la technologie médicale, a annoncé sa participation à la Wells Fargo 2025 Healthcare Conference. La présentation de la société est prévue le mercredi 3 septembre 2025 à 8h00, heure de l'Est.
Les investisseurs et les personnes intéressées peuvent accéder au webdiffusion en direct de la présentation via le site des relations investisseurs de BD à l'adresse investors.bd.com. Un enregistrement sera mis en ligne sur la même plateforme après l'événement.
BD (NYSE:BDX), ein weltweit führendes Medizintechnikunternehmen, hat seine Teilnahme an der Wells Fargo 2025 Healthcare Conference angekündigt. Die Präsentation des Unternehmens ist für Mittwoch, den 3. September 2025, um 8:00 Uhr Eastern Time angesetzt.
Investoren und Interessierte können die Live-Webcast-Übertragung über die Investor-Relations-Website von BD unter investors.bd.com verfolgen. Eine Aufzeichnung wird nach Abschluss der Veranstaltung auf derselben Plattform zur Verfügung gestellt.
- None.
- None.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-wells-fargo-2025-healthcare-conference-302529820.html
SOURCE BD (Becton, Dickinson and Company)